N-{(4R)-4-(4-Methoxyphenyl)-3-[2-(4-methoxyphenyl)ethyl]-2-oxo-1- imidazolidinyl}methanesulfonamide

Modify Date: 2024-09-15 11:42:48

N-{(4R)-4-(4-Methoxyphenyl)-3-[2-(4-methoxyphenyl)ethyl]-2-oxo-1- imidazolidinyl}methanesulfonamide Structure
N-{(4R)-4-(4-Methoxyphenyl)-3-[2-(4-methoxyphenyl)ethyl]-2-oxo-1- imidazolidinyl}methanesulfonamide structure
Common Name N-{(4R)-4-(4-Methoxyphenyl)-3-[2-(4-methoxyphenyl)ethyl]-2-oxo-1- imidazolidinyl}methanesulfonamide
CAS Number 1000306-34-2 Molecular Weight 419.49500
Density N/A Boiling Point N/A
Molecular Formula C20H25N3O5S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of N-{(4R)-4-(4-Methoxyphenyl)-3-[2-(4-methoxyphenyl)ethyl]-2-oxo-1- imidazolidinyl}methanesulfonamide


KVI-020 is an orally active, potent and selective blocker of the atrial potassium channel Kv1.5, with an IC50 of 480 nM. KVI-020 can inhibits hERG, with an IC50 of 15100 nM. KVI-020 is a potent antiarrhythmic agent, and can be used for atrial fibrillation (AF) research[1].

 Names

Name N-{(4R)-4-(4-Methoxyphenyl)-3-[2-(4-methoxyphenyl)ethyl]-2-oxo-1- imidazolidinyl}methanesulfonamide

  Biological Activity

Description KVI-020 is an orally active, potent and selective blocker of the atrial potassium channel Kv1.5, with an IC50 of 480 nM. KVI-020 can inhibits hERG, with an IC50 of 15100 nM. KVI-020 is a potent antiarrhythmic agent, and can be used for atrial fibrillation (AF) research[1].
Related Catalog
Target

IC50: 480 ± 44 nM (Kv1.5), 15100 nM (hERG)[1]

References

[1]. Blass BE, et al. Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmia. J Med Chem. 2009 Nov 12;52(21):6531-4.

 Chemical & Physical Properties

Molecular Formula C20H25N3O5S
Molecular Weight 419.49500
Exact Mass 419.15100
PSA 96.56000
LogP 3.53690